As GLP-1 receptor agonists reshape obesity treatment, a new medical perspective published in JAMA, underscores a persistent gap in care: integrating exercise into weight management in ways patients can sustain.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗